Sanofi To Expand Vaccine Manufacturing Facility in France
By

By
Sanofi is investing EUR 170 million ($201 million) to expand a vaccine manufacturing site in Val de Reuil, France. The new facility will allow Sanofi Pasteur, the vaccines global business…

Merck KGaA Opens New Life-Science Center for Scientific Collaboration
By

By
Merck KGaA has opened a new life-science center in Burlington, Massachusetts. The new center is positioned to serve as a regional hub for scientific advancement and customer collaboration. The new…

EMA To Launch Updated EudraVigilance System
By

By
The European Medicines Agency (EMA) plans to launch a new version of EudraVigilance, the European information system of suspected adverse reactions to medicines that are authorized or being studied in…

NJIT, Rutgers Form NJ Continuous Manufacturing Institute
By

By
Rutgers University and the New Jersey Innovation Institute, a corporation of the New Jersey Institute of Technology, plan to form the New Jersey Continuous Manufacturing Institute (NJCMI) to advance manufacturing…

EDQM, Anvisa Sign MoU for Information Sharing
By

By
The European Directorate for the Quality of Medicines & HealthCare (EDQM), a body responsible for the European Pharmacopoeia, and Agência Nacional de Vigilância Sanitária (Anvisa), the national health surveillance agency…

Switzerland To Simplify Cross-Border Inspections
By

By
The Swiss Agency for Therapeutic Products (Swissmedic), the national pharmaceutical regulatory authority in Switzerland, reports on new measures, taking effect January 1, 2018, regarding cross-border inspections, including inspections carried out…

FDA Issues Draft Guidance for Post-CRL Procedures in ANDA Applications
By

By
The US Food and Drug Administration (FDA) has issued draft guidance, Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA, to help applicants understand how to best respond…

Pfizer, J&J Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Pfizer and J&J. Editor’s Note: This article was updated on a continuous basis for news…

Merck & Co., J&J, Lilly, and Pfizer Lead Pipeline News
By

By
A roundup of the latest drug pipeline news, including from the pharmaceutical majors, featuring news from Merck & Co., J&J, Lilly, Astellas, and Pfizer. Editor’s Note: This article was updated…

Brammer Bio Partners in Gene Therapy
By

By
Brammer Bio, a Lexington, Massachusetts-headquartered cell and gene therapy contract development and manufacturing organization, has partnered with Abeona Therapeutics, a Dallas, Texas-headquartered clinical-stage biopharmaceutical company, to manufacture a gene therapy…